Giovanna Leonardi

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

Antonio Palumbo, Davide Rossi, Maide Cavalli et al. · Journal of Clinical Oncology · 2010 · 426 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles

Giovanni Emilia, Mario Luppi, Patrizia Zucchini et al. · Blood · 2007 · 91 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial

Ilaria Saltarella, Fortunato Morabito, Nicola Giuliani et al. · Journal of Hematology & Oncology · 2019 · 58 citations · Full text

Medicine, Hematology, Oncology +16

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

Rossana Maffei, Silvia Martinelli, Rita Santachiara et al. · Blood · 2010 · 57 citations · Full text

Medicine, Hematology, Oncology +9

Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients

Sara Bringhen, Alessandra Larocca, Davide Rossi et al. · Blood · 2010 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +14